Skip to content

ALLR - Allarity Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Allarity Therapeutics Inc

ALLR · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

ALLRAllarity Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $2.35
52-wk low: $0.77
Prev close: $1.54
Mkt cap: $22.8M
Beta: 0.51
P/S: 66.0x

Smart money

6 funds hold a position.

Real smart money

Funds holding this stock

6 holders

Combined position$759K

JS
Jim Simons
Q2 2026 13F
$428K
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Reported Aug 14, 2026

Earnings came in 16.0% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $23M

Valuation

P/S65.95
P/B6.07

Quality

Operating margin-10752.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ALLR
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $22.75M
Beta: 0.51

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

6.1x

Profit margin

+0.0%

Op margin

-10752.0%

ROE

-87.9%

$118K

position

TS

Two Sigma

Q2 2026 13F

$35K

position

3 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 3 holders

Coverage gaps for ALLR

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.21+16.0%

-$0.25 expected

Next report

Reports Aug 21, 2026, today

EPS expected

-$0.25

-$0.25 to -$0.25

Revenue expected

$0.00

1 analysts

Last 30 days

0up1down

Analysts cutting estimates

-87.9%

ROA-23.7%

Growth

Beta0.51